Dr Richard Lesniewski | President and CEO
Madison Vaccines Inc.

Dr Richard Lesniewski, President and CEO, Madison Vaccines Inc.

Richard (Rick) Lesniewski, Ph.D. is co-founder, President, and CEO of Madison Vaccines Incorporated (MVI), a Madison, Wisconsin biotech developing plasmid DNA vaccines for patients with malignant prostate cancer.  His 30 years of experience in biopharmaceutical drug research, diagnostics, and biotech include senior leadership positions at Abbott Laboratories and GlaxoSmithKline Pharmaceuticals. Rick’s industry tenure focused on drug discovery, and preclinical and translational development of human monoclonal antibodies, ADC’s and PD-1 checkpoint inhibitors.  His experience also includes technology assessment and licensing, and directing large pharma/biotech strategic alliances.  Rick is a member of Wisconsin Investment Partners, sits on the Board of Directors of Invenra, DNA Star, and SCARAB Genomics, and he is a member of the Scientific Advisory Board for Alethia Biopharmaceuticals. 

back to speakers